ZNTL — Zentalis Pharmaceuticals, Inc. | XLV Holdings | StockAdder

(ZNTL)

Zentalis Pharmaceuticals, Inc.

Live chart and latest ZNTL stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

ZNTL News

What's Behind The Surge In Zentalis Stock? - Zentalis Pharmaceuticals (NASDAQ:ZNTL)

Apr 10, 2026 Yahoo Finance

Following a 13% decline over last year, recent gains may please Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) institutional owners

Jan 8, 2026 Stock Titan

Ovarian cancer drug moves toward pivotal trials with 400mg dose

Apr 9, 2026 timothysykes.com

Zentalis Pharmaceuticals: Price Target Boost Sparks Speculative Momentum

Apr 11, 2026 Gotrade

Zentalis Pharmaceuticals, Inc. Common Stock (ZNTL) Stock Price Today & Analysis

Jan 13, 2026 simplywall.st

Zentalis Pharmaceuticals, Inc.'s (NASDAQ:ZNTL) Shares Bounce 28% But Its Business Still Trails The Industry

Jan 7, 2026 Investing.com

Walters group buys Zentalis Pharmaceuticals (ZNTL) shares for $7.7m

Jan 8, 2026 Seeking Alpha

Zentalis Pharmaceuticals: Hanging On For One Last Shot At PROC Approval (ZNTL)

Nov 18, 2025 GlobeNewswire

Zentalis Pharmaceuticals Reports Full Year 2025 Financial Results and Operational Updates

Mar 26, 2026 Quiver Quantitative

Zentalis Pharmaceuticals Stock (ZNTL) Opinions on Azenosertib Development Update | ZNTL Stock News

Jan 9, 2026 Yahoo Finance

A Look At Zentalis Pharmaceuticals (ZNTL) Valuation After Azenosertib Progress And Insider Buying

Jan 11, 2026 Stock Titan

Two new Zentalis hires get stock options priced at $2.57

Apr 1, 2026 Stock Titan

Azenosertib 400mg dose to anchor Zentalis (NASDAQ: ZNTL) late-stage ovarian cancer trials

Apr 9, 2026 Yahoo Finance

We're Keeping An Eye On Zentalis Pharmaceuticals' (NASDAQ:ZNTL) Cash Burn Rate

Dec 3, 2025 Stock Titan

Cancer drug developer says cash lasts into late 2027 as key trial nears